Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021;81(18):3708–30.
Article PubMed PubMed Central CAS Google Scholar
Cao D, Khan Z, Li X, Saito S, Bernstein EA, Victor AR, et al. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism. Cardiovascular Res. 2023;119(9):1825–41.
Desgrouas C, Thalheim T, Cerino M, Badens C, Bonello-Palot N. Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans. Cardiovascular Res. 2024;120(3):237–48.
Zhou H, Ding X, Yang Q, Chen S, Li Y, Zhou X, Wu S. Associations of Hypertriglyceridemia Onset Age with Cardiovascular Disease and all-cause mortality in adults: a Cohort Study. J Am Heart Assoc. 2022;11(20):e026632.
Article PubMed PubMed Central CAS Google Scholar
Yu D, Wang Z, Zhang X, Qu B, Cai Y, Ma S, et al. Remnant cholesterol and Cardiovascular Mortality in patients with type 2 diabetes and Incident Diabetic Nephropathy. J Clin Endocrinol Metab. 2021;106(12):3546–54.
Zheng S, Tsao PS, Pan C. Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation. Nat Commun. 2024;15(1):5652.
Article PubMed PubMed Central CAS Google Scholar
Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, Cao Y. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.
Article PubMed PubMed Central Google Scholar
Yi M, Li J, Chen S, Cai J, Ban Y, Peng Q, et al. Emerging role of lipid metabolism alterations in Cancer stem cells. J Experimental Clin cancer Research: CR. 2018;37(1):118.
Article PubMed Central Google Scholar
Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, Xu Q. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (London England). 2022;42(12):1234–56.
Agarwal R, Bills JE, Light RP. Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the obesity paradox? Hypertension (Dallas, Tex: 1979). 2010;56(5):893–900.
Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301–13.
Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, Kostara CE. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics (Basel Switzerland). 2023;13(5).
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.
Article PubMed PubMed Central Google Scholar
Liu X, Wu Q, Yan G, Duan J, Chen Z, Yang P, et al. Cardiometabolic index: a new tool for screening the metabolically obese normal weight phenotype. J Endocrinol Investig. 2021;44(6):1253–61.
Zuo YQ, Gao ZH, Yin YL, Yang X, Feng PY. Association between the Cardiometabolic Index and Hyperuricemia in an Asymptomatic Population with normal body Mass Index. Int J Gen Med. 2021;14:8603–10.
Article PubMed PubMed Central CAS Google Scholar
Wakabayashi I, Daimon T. The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–8.
Article PubMed CAS Google Scholar
Zha F, Cao C, Hong M, Hou H, Zhang Q, Tang B, et al. The nonlinear correlation between the cardiometabolic index and the risk of diabetes: a retrospective Japanese cohort study. Front Endocrinol. 2023;14:1120277.
Wang X, He B. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm. 2024;5(8):e651.
Article PubMed PubMed Central CAS Google Scholar
Wakabayashi I, Sotoda Y, Hirooka S, Orita H. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. 2015;446:231–6.
Article PubMed CAS Google Scholar
Xu B, Wu Q, La R, Lu L, Abdu FA, Yin G, et al. Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study. Cardiovasc Diabetol. 2024;23(1):212.
Article PubMed PubMed Central CAS Google Scholar
Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Reviews Cardiol. 2024;21(9):617–31.
Ng CH, Teng ML, Chew NW, Chan KE, Yong JN, Quek J, et al. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals. Expert Rev Gastroenterol Hepatol. 2022;16(9):895–901.
Article PubMed CAS Google Scholar
Yokomichi H, Nagai A, Hirata M, Tamakoshi A, Kiyohara Y, Kamatani Y, et al. Statin use and all-cause and cancer mortality: BioBank Japan cohort. J Epidemiol. 2017;27(3S):S84–91.
Article PubMed PubMed Central Google Scholar
Dursun M, Besiroglu H, Otunctemur A, Ozbek E. Is Cardiometabolic Index a predictive marker for renal cell Cancer aggressiveness? Prague Med Rep. 2019;120(1):10–7.
Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci data. 2016;3:160096.
Article PubMed PubMed Central CAS Google Scholar
Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011–2014. Vital and health statistics Series 2, Data evaluation and methods research. 2014(162). pp. 1–33.
Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital and health statistics Ser 1, Programs and collection procedures. 2013(56). pp. 1–37.
Livingston M, Laslett AM, Dietze P. Individual and community correlates of young people’s high-risk drinking in Victoria, Australia. Drug Alcohol Depend. 2008;98(3):241–8.
Vital signs. Current cigarette smoking among adults aged ≥ 18 years–United States, 2005–2010. MMWR Morbidity Mortal Wkly Rep. 2011;60(35):1207–12.
Kushner RF, Ryan DH. Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews. JAMA. 2014;312(9):943–52.
Article PubMed CAS Google Scholar
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (Cambridge, Mass). 2007;18(6):805 – 35.
Stensrud MJ, Hernán MA. Why Test Proportional Hazards? JAMA. 2020;323(14):1401–2.
Goldsmith JR, Kordysh E. Why dose-response relationships are often non-linear and some consequences. J Expo Anal Environ Epidemiol. 1993;3(3):259–76.
Wu J, Wang Q, He X. Enhancing the interpretation of continuous outcomes and subgroup analyses in systematic reviews. JAMA Pediatr. 2024;178(6):627.
Chen C-C, Li T-C, Chang P-C, Liu C-S, Lin W-Y, Wu M-T, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism. 2008;57(4):544–8.
Article PubMed CAS Google Scholar
Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi BS, et al. The triglyceride Paradox in Stroke survivors: a prospective study. Neurosci J. 2013;2013:870608.
Article PubMed PubMed Central Google Scholar
Xia TL, Li YM, Huang FY, Chai H, Huang BT, Li Q, et al. The triglyceride paradox in the mortality of coronary artery disease. Lipids Health Dis. 2019;18(1):21.
留言 (0)